Prenetics rises on Q2 revenue jump
18/08/2026 13:53
BUZZ-Prenetics rises on Q2 revenue jump ** Shares of consumer health company Prenetics PRE.O rise 5.1% to $20.36 premarket
** The supplement maker reports Q2 revenue of $46.50 million, compared to $12 million in the previous year's quarter, reflecting a 288% increase year-over-year
** PRE raises FY revenue view to a range of $220 mln to $230 mln, compared to a previous projection of $190 mln to $210 mln
** As of last close, PRE stock was up ~23% YTD
(Reporting by Padmanabhan Ananthan)
Recent news on Prenetics Global
See all newsBrief: Prenetics’ Im8 Announces Two-Time Golden Globe-Nominated Actress And Producer Lily Collins As Im8 Global Ambassador And Shareholder In Multi-Year Partnership
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Prenetics Global Ltd reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics